Concerning the basics of PD prescription writing–and only the basics, since there’s lots to say about this interesting topic–the minimum prescription should specify the following: 1. What kind of PD does the patient use: for the most part,…
I stumbled across a bit of Nephrology/Urology history the other day while strolling around a hospital in Paris: this plaque commemorating one of the key steps in the invention of ureteroscopy and cystoscopy. The plaque can be found…
Happy New Year’s Eve! I found the results of last week’s poll to be surprising…well, I guess I shouldn’t be too shocked to see that Nephrology Fellows won the “hardest working fellow in show business” award, being that…
Well, I had hoped to be more of an active blogger during my holiday vacation this year, but my internet access has been much spottier than desired way out in the boondocks of Western France (not that I…
The readers have spoken and it is time to announce the results of the hypothetical “Mount Rushmore of Nephrology”: the four Nephrology Pioneers whose contributions have mattered most, and deserve to have their imagery preserved forever on a…
The Angiojet Rheolytic Thrombectomy System is a medical device currently used to re-establish blood flow in a variety of settings. Briefly, a catheter is introduced into an area of thrombosis and a saline stream is directed towards the thrombus of…
Red urine: it’s not always hematuria. The first step in evaluating the patient who complains of grossly red urine is to perform a standard urinalysis, focusing on (a) whether or not the dipstick turns heme-positive, and (b) whether…
Question: Who is the most important medical subspecialist for a patient with CKD to have regular contact with? Is it the nephrologist? A case could be made, relying purely on mortality statistics, that it’s actually the cardiologist. CKD/ESRD…
The study of AKI/ATN has relied heavily on one particular animal model: the warm ischemia-reflow model (often referred to as “ischemia-reperfusion injury”), in which one of the renal arteries is transiently ligated off for a set period of…
The results of last week’s poll on IgA Nephropathy are in: 90% of individuals correctly identified that the only treatment shown in randomized controlled trials to consistently benefit patients with IgA Nephropathy is ACE-inhibitors and/or ARBs. The response…
